Story perspectives

Study Reveals MUD Transplants Boost Survival in Leukemia Patients

11/5/2025

35 2

Summary

Story summary

A study found that matched unrelated donor (MUD) hematopoietic cell transplantation (HCT) significantly improves survival versus haploidentical HCT for adults with acute leukemia or myelodysplastic syndrome.
Analysis included 5,873 patients from 143 U.S. centers, assessing overall survival and GVHD-free relapse-free survival.
MUD recipients had a 15% lower three-year mortality risk than haploidentical recipients.
The study emphasizes prioritizing MUD donors for optimal patient outcomes, noting younger donor age yields better results.

1 of 1

Story summary

A study found that matched unrelated donor (MUD) hematopoietic cell transplantation (HCT) significantly improves survival versus haploidentical HCT for adults with acute leukemia or myelodysplastic syndrome.
Analysis included 5,873 patients from 143 U.S. centers, assessing overall survival and GVHD-free relapse-free survival.
MUD recipients had a 15% lower three-year mortality risk than haploidentical recipients.
The study emphasizes prioritizing MUD donors for optimal patient outcomes, noting younger donor age yields better results.